Results 1 - 10 of 73
[PROJECT] RN4CAST - Nurse Forecasting: Human Resources Planning in Nursing
ID: 223468
Start date: 2009-01-01, End date: 2011-12-31
Current human resources planning models in nursing are unreliable and ineffective as they consider volumes, but ignore effects on quality in patient care. The project RN4CAST aims innovative forecasting methods by addressing not only volumes, but quality of nursing staff as w...
Programme: FP7-HEALTH
Record Number: 91239
Last updated on: 2017-05-25
[PROJECT] ASFRISK - Evaluating and controlling the risk of African swine fever in the EU
ID: 211691
Start date: 2008-04-01, End date: 2011-09-30
African swine fever (ASF) in EU member states is currently confined to Italy (Sardinia), it was recently introduced to Caucasian regions and it is highly prevalent in sub-Saharan African countries. In both the EC and Africa changes in the epidemiology of the disease have rece...
Programme: FP7-KBBE
Record Number: 88394
Last updated on: 2017-05-29
[PROJECT] MM4TB - More Medicines for Tuberculosis
ID: 260872
Start date: 2011-02-01, End date: 2016-07-31
The More Medicines for Tuberculosis (MM4TB) consortium evolved from the highly successful FP6 project, New Medicines for TB (NM4TB), that delivered a candidate drug for clinical development two years ahead of schedule. Building on these firm foundations and exploiting its pro...
Programme: FP7-HEALTH
Record Number: 98754
Last updated on: 2017-05-26
[REPORT SUMMARY] Information on identifying breeding sites of C. imicola & on establishing lab colonies of C. imicola has been acquired
C. imicola is the major vector of BT V in southern Europe and Africa. Its breeding sites can now be broadly classified according to soil type, pH and carbon percentage. However, no correlation between any of these characteristics and abundance was detected. Moisture content an...
Programme: FP5-LIFE QUALITY
Record Number: 40086
Last updated on: 2006-02-28
[REPORT SUMMARY] Evidence of natural reassortment between bluetongue vaccine viruses & field strains of bluetongue virus has been found
One of the concerns related to the use of live attenuated virus vaccines is that in dually infected hosts (vertebrate or insect vector) such vaccine viruses may reassort with field strains producing progeny viruses of uncertain virulence - though evidence of the occurrence of ...
Programme: FP5-LIFE QUALITY
Record Number: 40093
Last updated on: 2006-02-28
[PROJECT] MUVAPRED - Mucosal Vaccines for Poverty Related Diseases
ID: 503240
Start date: 2003-12-01, End date: 2009-11-30
The project is focused on the development of mucosal vaccines against AIDS and tuberculosis (TB) and is based on the use of antigens validated as safe and effective in animal models. Mucosal vaccines present advantages of practical and social relevance when compared to parente...
Programme: FP6-LIFESCIHEALTH
Record Number: 75286
Last updated on: 2011-04-12
[PROJECT] CCH FEVER - Crimean Congo Hemorrhagic Fever; Modern Approaches to Diagnostics, Surveillance, Prevention, Therapy and Preparedness
ID: 260427
Start date: 2010-10-01, End date: 2015-03-31
Over the last years, large outbreaks of Crimean Congo Hemorrhagic fever virus (CCHFV) in several European countries and neighbouring areas are on the rise. This disease poses a great threat to public health due to its high mortality rate, modes of transmission and geographica...
Programme: FP7-HEALTH
Record Number: 96779
Last updated on: 2017-05-26
[PROJECT] NEUTNET - STANDARDISATION OF HIV NEUTRALISATION ASSAYS TO BE USED IN VACCINE RESEARCH AND CLINICAL TRIALS
ID: 12190
Start date: 2005-01-01, End date: 2007-03-31
The efficacy of viral vaccines can be confirmed by large sero-epidemiological studies where occurrence of a certain type(s) of functional antibody correlates with protection. In general, antibodies with virus neutralising function are the best correlates o f protection. Follow...
Programme: FP6-LIFESCIHEALTH
Record Number: 74056
Last updated on: 2008-07-21
[PROJECT] ARTESUNATE - Research & development of rectal artesunate (ARTESUNATE)
ID: QLK2-CT-2001-01430
Start date: 2001-07-01, End date: 2004-06-30
The proposal is to complete the chemical development, efficacy and safety evaluation of an ant malarial articulate, which has not yet been registered for use in the EU or US. The intended beneficiary is a patient living in or travelling to a malaria endemic country. The drug i...
Programme: FP5-LIFE QUALITY
Record Number: 58979
Last updated on: 2005-04-12
[PROJECT] BLUETONGUE VACCINATI - Development of a safe, efficacious bluetongue virus vaccination strategy for europe (BLUETONGUE VACCINATION)
ID: QLK2-CT-2001-01722
Start date: 2001-12-01, End date: 2005-05-31
Bluetongue virus (BTV) has a track record of incursion into the EU & causing severe disease & financial losses to our livestock industry. However, the EU has no coherent vaccination policy, which makes BTV incursions difficult or impossible to control. This project will enable...
Programme: FP5-LIFE QUALITY
Record Number: 58978
Last updated on: 2005-04-12
List retrieved on: 2017-08-02
